Verification register Bio, Health & Neuro
Living definition
What is Unity Biotechnology UBX1325 (foselutoclax) senolytic?
Longevity & Aging Biotech Bio, Health & Neuro
- As of
- 2026-09-30
- Revision
- 2026-10-06.1
- Method
- v1.4.0
Definition
The term, in context
AI-assisted draft · approved dataset
Unity Biotechnology UBX1325, also called foselutoclax, is a senolytic drug candidate designed to selectively clear aged, dysfunctional cells from tissue such as the eye.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-30, verified readiness is 20 (claimed 35, reported 20, gap 15) — Weak evidence strength; current signals suggest Treat foselutoclax as an investigational retinal-disease candidate.
The readiness fact belongs to the canonical Readiness Verdict for Unity Biotechnology UBX1325 (foselutoclax) senolytic.
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06